NewCardio appoints Kowey to scientific advisory board
NewCardio, a cardiac diagnostic and services company, has appointed Peter R. Kowey MD, a cardiologist who has served on several committees and is a fellow of several professional organizations, to its scientific advisory board.
Kowey is currently president of the heart center of the Lankenau Hospital Main Line Health System in Wynewood, Pa. He also is professor of medicine and clinical pharmacology at Jefferson Medical College in Philadelphia and previously served as an adjunct professor of pharmacology at MCP-Hahnemann School of Medicine in Philadelphia, according to the Santa Clara, Calif.-based company.
“As we commercialize our QTinno product and bring modern computer processing to thorough QT testing, we expect that Dr. Kowey’s longstanding relationships with some of the largest pharmaceutical companies in the world…should help our product meet the needs of the industry. We welcome Dr. Kowey to NewCardio and look forward to benefiting from his expertise as we develop our 3D platform technology,” said Branislav Vajdic, PhD, president and CEO.
Kowey is currently president of the heart center of the Lankenau Hospital Main Line Health System in Wynewood, Pa. He also is professor of medicine and clinical pharmacology at Jefferson Medical College in Philadelphia and previously served as an adjunct professor of pharmacology at MCP-Hahnemann School of Medicine in Philadelphia, according to the Santa Clara, Calif.-based company.
“As we commercialize our QTinno product and bring modern computer processing to thorough QT testing, we expect that Dr. Kowey’s longstanding relationships with some of the largest pharmaceutical companies in the world…should help our product meet the needs of the industry. We welcome Dr. Kowey to NewCardio and look forward to benefiting from his expertise as we develop our 3D platform technology,” said Branislav Vajdic, PhD, president and CEO.